Previous Close | 10.01 |
Open | 10.02 |
Bid | 10.03 x 1000 |
Ask | 10.05 x 1200 |
Day's Range | 10.01 - 10.04 |
52 Week Range | 9.59 - 10.42 |
Volume | |
Avg. Volume | 14,506 |
Market Cap | 125.928M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Mar 30, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ATLANTA, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (“Altitude”) (NASDAQ:ALTU) a publicly traded special purpose acquisition company (SPAC), today announced the signing of a non-binding letter-of-intent (“LOI”) for a business combination with a leading global medical device manufacturer (the “Target”). The Target, a leader in its medical device field with a product that is commercially available and approved for use in over 30 countries, seeks additional expansion in the U.S. a
ATLANTA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Altitude Acquisition Corp. (“Altitude”) (NASDAQ:ALTU) a publicly traded special purpose acquisition company, has entered into negotiations to merge with a leading global medical device manufacturer in a deal that pegs the enterprise value of the company at approximately $480 million. The proposed transaction calls for the combined company to have at least $20 million in net cash at time of closing. The target, a leader in its medical device field with a
If you want to know who really controls Altitude Acquisition Corp. ( NASDAQ:ALTU ), then you'll have to look at the...